AC2	Aptima Combo 2
ATV	Aptima Trichomonas vaginalis
AHPV	Aptima Human Papilloma Virus
BV	Bacterial vaginosis
CT	Chlamydia trachomatis
CI	Confidence interval
CIN-II	Cervical intraepithelial lesion
FSW	Female sex workers
FCU	First-catch urine
HC-II	Hybrid Capture II
HSIL	High-grade squamous intraepithelial lesion
HR-HPV	High-risk human papilloma virus
HIC	High-Income Country
HPV	Human Papilloma Virus
LMIC	Low- and middle-income countries
LCR	Ligase chain reaction
MG	Mycoplasma genitalium
mPCR/RLB	Multiplex polymerase chain reaction/reverse line blot
NG	Neisseria gonorrhoea
NPV	Negative predictive value
NAAT	Nucleic Acid Amplification Test
P-VSCT	Physician-collected specimen collection and transport
POCT	Point-of-care testing
PPV	Positive predictive value
POC	Point-of-Care
PCR	Polymerase Chain Reaction
PC-VS	Patient-collected vaginal swab
PRISMA-ScR	Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for Scoping Reviews
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-analyses
STI	Sexually Transmitted infections
SCT	Self-collection and transport
S-VSCT	Self-collected specimen collection and transport
SIS	Single intravaginal swab
SVS	Self-collected vaginal swab
TV	Trichomonas vaginalis
USA	United States of America
UK	United Kingdom
VVC	Vulvovaginal Candida